Zacks: Analysts Anticipate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Announce $0.64 EPS

Equities research analysts expect DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to post earnings per share of $0.64 for the current quarter, according to Zacks. Eight analysts have issued estimates for DENTSPLY SIRONA’s earnings, with the highest EPS estimate coming in at $0.70 and the lowest estimate coming in at $0.55. DENTSPLY SIRONA posted earnings of ($0.18) per share in the same quarter last year, which indicates a positive year-over-year growth rate of 455.6%. The firm is expected to issue its next quarterly earnings results on Thursday, August 5th.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.82 per share for the current year, with EPS estimates ranging from $2.67 to $2.89. For the next year, analysts expect that the business will post earnings of $3.13 per share, with EPS estimates ranging from $2.95 to $3.28. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 6th. The medical instruments supplier reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.17. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $944.89 million. DENTSPLY SIRONA had a positive return on equity of 7.13% and a negative net margin of 1.40%. The company’s revenue was up 17.5% on a year-over-year basis. During the same period last year, the firm earned $0.43 earnings per share.

XRAY has been the subject of a number of research reports. Barrington Research lifted their price target on DENTSPLY SIRONA from $71.00 to $77.00 and gave the stock an “outperform” rating in a research note on Friday, May 7th. Piper Sandler lifted their price target on DENTSPLY SIRONA from $70.00 to $75.00 and gave the stock an “overweight” rating in a research note on Thursday, May 6th. Robert W. Baird lifted their price target on DENTSPLY SIRONA from $71.00 to $78.00 and gave the stock an “outperform” rating in a research note on Friday, May 7th. Barclays lifted their price target on DENTSPLY SIRONA from $50.00 to $55.00 and gave the stock an “underweight” rating in a research note on Tuesday, March 2nd. Finally, HC Wainwright lifted their price target on DENTSPLY SIRONA from $60.00 to $72.00 and gave the stock a “neutral” rating in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $60.90.

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 5,000 shares of the business’s stock in a transaction dated Thursday, March 4th. The shares were bought at an average price of $58.95 per share, with a total value of $294,750.00. Following the completion of the acquisition, the director now owns 13,850 shares in the company, valued at approximately $816,457.50. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Eric Brandt sold 7,600 shares of DENTSPLY SIRONA stock in a transaction that occurred on Wednesday, March 17th. The shares were sold at an average price of $63.21, for a total value of $480,396.00. Following the sale, the director now directly owns 38,131 shares in the company, valued at approximately $2,410,260.51. The disclosure for this sale can be found here. Company insiders own 0.53% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. HighTower Advisors LLC raised its holdings in shares of DENTSPLY SIRONA by 1.0% during the first quarter. HighTower Advisors LLC now owns 17,007 shares of the medical instruments supplier’s stock valued at $1,085,000 after buying an additional 171 shares during the last quarter. Cerity Partners LLC raised its holdings in DENTSPLY SIRONA by 1.7% during the fourth quarter. Cerity Partners LLC now owns 10,697 shares of the medical instruments supplier’s stock worth $560,000 after purchasing an additional 181 shares in the last quarter. CI Investments Inc. raised its holdings in DENTSPLY SIRONA by 34.5% during the fourth quarter. CI Investments Inc. now owns 718 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 184 shares in the last quarter. Quadrant Capital Group LLC raised its holdings in DENTSPLY SIRONA by 40.3% during the first quarter. Quadrant Capital Group LLC now owns 651 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 187 shares in the last quarter. Finally, First Manhattan Co. raised its holdings in DENTSPLY SIRONA by 2.2% during the first quarter. First Manhattan Co. now owns 8,729 shares of the medical instruments supplier’s stock worth $557,000 after purchasing an additional 192 shares in the last quarter. 96.00% of the stock is currently owned by institutional investors.

Shares of DENTSPLY SIRONA stock traded up $1.12 during trading hours on Monday, hitting $68.95. 900,611 shares of the company’s stock traded hands, compared to its average volume of 1,669,380. The stock has a 50 day simple moving average of $65.71 and a 200-day simple moving average of $57.49. The company has a quick ratio of 2.38, a current ratio of 3.10 and a debt-to-equity ratio of 0.47. The company has a market cap of $15.05 billion, a PE ratio of -299.78, a PEG ratio of 5.06 and a beta of 0.98. DENTSPLY SIRONA has a twelve month low of $38.49 and a twelve month high of $69.54.

The firm also recently announced a quarterly dividend, which was paid on Friday, April 9th. Shareholders of record on Friday, March 26th were issued a $0.10 dividend. The ex-dividend date was Thursday, March 25th. This represents a $0.40 dividend on an annualized basis and a yield of 0.58%. DENTSPLY SIRONA’s dividend payout ratio is currently 16.33%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: How does new data get added to a blockchain?

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.